Multiple Assemblies exist for SMTL entry 7myc
Structure of proline utilization A with the FAD covalently modified by tetrahydrothiophene; X-RAY DIFFRACTION 1.90 Å

	SMTL ID 7myc.1 Ligands [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-5-[(2R)-tetrahydrothiophen-2-yl]-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl}-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name); 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE; SULFATE ION; TRIETHYLENE GLYCOL; FORMIC ACID Polypeptides Bifunctional protein PutA Oligo-state monomer
	SMTL ID 7myc.2 Ligands [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-5-[(2R)-tetrahydrothiophen-2-yl]-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl}-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name); MAGNESIUM ION; 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE; SULFATE ION; TRIETHYLENE GLYCOL; DI(HYDROXYETHYL)ETHER; FORMIC ACID Polypeptides Bifunctional protein PutA Oligo-state monomer
	SMTL ID 7myc.3 Ligands [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-5-[(2R)-tetrahydrothiophen-2-yl]-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl}-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name); 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE; SULFATE ION; TRIETHYLENE GLYCOL; FORMIC ACID; MAGNESIUM ION; DI(HYDROXYETHYL)ETHER Polypeptides Bifunctional protein PutA Oligo-state homo-dimer